Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Tracon Pharmaceuticals Announces 15 Million Common Stock Purchase Agreement With Aspire Capital Fund Llc is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
TRACON Pharmaceuticals Announces Reverse Stock Split
Stockholders of record who would otherwise be entitled to receive a fractional share will receive one full share of post-reverse split common stock. TRACON has chosen its transfer agent, Equiniti ... Read More
TRACON Pharmaceuticals, Inc. Common Stock (TCON)
Nasdaq provides press releases highlighting valuable information sent out by companies. Here you can find the company’s latest financial figures, contact information, and source version of the ... Read More
Buy Rating Reaffirmed for TRACON Pharmaceuticals Post-Reverse Split and Envafolimab Valuation Update
TRACON Pharmaceuticals (TCON – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Edward White from H.C. Wainwright reiterated a Buy rating on the ... Read More
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
RADNOR, Pa., April 18, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced the pricing ... Read More
Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split
BOSTON, MA / ACCESSWIRE / April 19, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common ... Read More
TRACON Pharmaceuticals Announces Reverse Stock Split
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals ... share of common stock, par value $0.001 per share, and there are now approximately 2.6 million shares of common stock ... Read More
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 91,050 shares of common stock at the ... This press release shall not constitute an offer ... Read More
TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Reverse Stock Split
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals ... share of common stock, par value $0.001 per share, and there are now approximately 2.6 million shares of common stock ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus